Provided by Tiger Trade Technology Pte. Ltd.

Prothena Corp PLC

8.88
-0.0900-1.00%
Post-market: 8.880.00000.00%17:47 EST
Volume:490.50K
Turnover:4.34M
Market Cap:478.01M
PE:-1.96
High:9.11
Open:9.00
Low:8.53
Close:8.97
52wk High:16.16
52wk Low:4.32
Shares:53.83M
Float Shares:40.09M
Volume Ratio:1.04
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5346
EPS(LYR):-4.5346
ROE:-63.62%
ROA:-26.40%
PB:1.70
PE(LYR):-1.96

Loading ...

Prothena announces poster presentation on TDP-43 CYTOPE program

TIPRANKS
·
Nov 20, 2025

Prothena Unveils Promising Preclinical Results for TDP-43 CYTOPE in ALS Mouse Model

Reuters
·
Nov 20, 2025

Prothena Announces Poster Presentation on Its Tdp-43 Cytope® Program at Neuroscience 2025

THOMSON REUTERS
·
Nov 20, 2025

Prothena Q3 Net Income USD -36.541 Million

Reuters
·
Nov 20, 2025

Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker

Benzinga
·
Nov 12, 2025

Prothena Highlights Positive Phase 2 Results for Coramitug in ATTR Amyloidosis

Reuters
·
Nov 11, 2025

Prothena Highlights Phase 2 Data for Coramitug (Formerly Prx004) Published in Circulation, Official Journal of Aha

THOMSON REUTERS
·
Nov 11, 2025

Stock Track | Prothena (PRTA) Soars 5% Pre-Market as H.C. Wainwright Boosts Price Target by 50%

Stock Track
·
Nov 07, 2025

Prothena price target raised to $30 from $20 at H.C. Wainwright

TIPRANKS
·
Nov 07, 2025

Prothena Corporation Plc : H.c. Wainwright Raises Target Price to $30 From $20

THOMSON REUTERS
·
Nov 07, 2025

RBC Capital Keeps Their Hold Rating on Prothena (PRTA)

TIPRANKS
·
Nov 07, 2025

Prothena Q3 net loss narrows to $36.5 mln

Reuters
·
Nov 07, 2025

Prothena Unveils Pipeline Update Highlighting Advances in Neurodegenerative Disease Therapies

Reuters
·
Nov 07, 2025

Prothena Corp Q3 Adj. EPS $(0.68) Beats $(0.69) Estimate, Sales $2.415M Miss $6.639M Estimate

Benzinga
·
Nov 07, 2025

Prothena Corporation PLC expected to post a loss of 69 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Prothena Corporation plc to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 31, 2025

Prothena Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Oct 28, 2025

Prothena price target raised to $20 from $14 at H.C. Wainwright

TIPRANKS
·
Oct 07, 2025

Prothena Corporation Plc : H.c. Wainwright Raises Target Price to $20 From $14

THOMSON REUTERS
·
Oct 07, 2025

BRIEF-Prothena's Partner Bristol Myers Squibb Obtains Fast Track Designation From US FDA For BMS-986446 For Treatment Of Alzheimer's Disease

Reuters
·
Oct 02, 2025